EIR Biocon Biologics India Jun 2017

Sandra Hughes FDA, Eileen Liu FDA$595.00 - Available Now

FDA investigators audited the Biocon Biologics India - Bengaluru, India facility and issued inspectional observation (via FDA 483) on 03 Jun 2017.

Product details

  • Category:
  • Inspection end: 03 Jun 2017
  • Location: Bengaluru, India
  • FEI: 3003981475
Add To Cart